ClinicalTrials.gov
public full text
Public Domain
Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer
The objective of this study is to use blood and urine proteomic and metabolomic features to monitor lung cancer immunotherapy response.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer#912400
- Detection of Early Lung Cancer by Serum Protein Expression Profiling#901578
- Identify Prognostic Biomarkers of Lung Cancer#884829
- Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry#1174946
- Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening#887899
Record · ID 1152743
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive